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Summary
In a survey of enzymes related to protein oxidation and cellular
redox state, we found activity of the redox enzyme thioredoxin
reductase (TXNRD) to be elevated in cells from long-lived species
of rodents, primates, and birds. Elevated TXNRD activity in long-
lived species reflected increases in the mitochondrial form,
TXNRD2, rather than the cytosolic forms TXNRD1 and TXNRD3.
Analysis of published RNA-Seq data showed elevated TXNRD2
mRNA in multiple organs of longer-lived primates, suggesting
that the phenomenon is not limited to skin-derived fibroblasts.
Elevation of TXNRD2 activity and protein levels was also noted in
liver of three different long-lived mutant mice, and in normal
male mice treated with a drug that extends lifespan in males.
Overexpression of mitochondrial TXNRD2 in Drosophila melano-
gaster extended median (but not maximum) lifespan in female
flies with a small lifespan extension in males; in contrast,
overexpression of the cytosolic form, TXNRD1, did not produce
a lifespan extension.
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Introduction
The rate at which aging leads to physiological decline, late-life
disease, and death varies greatly among species of birds, rodents, and
primates. Maximum lifespan varies from 2 years to over 100 years
among species of mammals. This variation is thought to represent
adaptation, across evolutionary timescales, to niches that reward
either rapid reproduction or slower, more sustained patterns of
development and reproductive investment (Stearns, 1992). This
variation in lifespan can be seen not just across the animal kingdom
but within individual animal clades. Maximum lifespan among
nonhuman primate species varies from 15 to 60 years. Maximum
lifespan among rodent species varies from 4 to 32 years, and
maximum lifespan among bird species varies from 5 to 70 years.
This implies that a long lifespan has evolved multiple times in different
clades. What strategies have been employed by these different groups
to extend lifespan and whether these strategies are conserved or
divergent among animal clades forms an interesting topic for
research. Understanding the mechanisms that different species have
employed to extend their lifespan has both medical implications for
developing treatments to age-associated diseases and academic
interest in understanding the factors which limit species lifespan and
whether such limitations are conserved across species and clades.
Comparative analysis of cultured cells from species that vary in
lifespan provides a powerful tool to identify factors which may regulate
the rate of aging. This approach has documented systematic variation,
among species of rodents, birds, and/or primates, in proteasome
structure and function (Pickering et al., 2015b), telomere length
(Gomes et al., 2011), stress kinase activation (Elbourkadi et al., 2014),
cadmium exclusion (Dostal et al., 2015), and resistance to oxidant injury
(Harper et al., 2007, 2011; Pickering et al., 2015a). Comparisons
between pairs of short- and long-lived species, such as comparisons
between laboratory mice and the naked mole rat (Rodriguez et al.,
2012) or long- and short-lived species of clams (Ungvari et al., 2011),
have also been informative. In a few cases, cellular traits shown to be
associated with longer lifespan in the comparative biology analyses
have also been modulated by genetic, dietary, or pharmacologic
interventions that extend lifespan in mice or invertebrates, including
analyses of heavy metal resistance (Barsyte et al., 2001; Salmon et al.,
2005; Dostal et al., 2015a), resistance to oxidative toxins (Salmon et al.,
2005; Harper et al., 2007, 2011; Ristow & Schmeisser, 2011), and
proteasome function (Rodriguez et al., 2012; Pickering et al., 2015b).
The dramatic recent increase in the range of sequenced genomes,
proteomes, and transcriptomes has facilitated the development of new
tools to dissect the differences in cell function behind this interspecies
variation. (Wright et al., 2010; Peng et al., 2015; Pickering et al.,
2015b).
Much circumstantial evidence links cellular resistance to oxidative
stress and organismal lifespan. Genetic, dietary, or drug manipulations
that extend lifespan in mice, flies, and worms often increase oxidative
stress resistance (Larsen, 1993; Landis et al., 2004; Salmon et al., 2005;
Lithgow & Miller, 2008). Cells from longer-lived species are often more
resistant to oxidative stress than cells derived from shorter-lived species
of the same clade (Harper et al., 2007, 2011; Pickering et al., 2015a). In
contrast, augmentation or knockdown of cellular antioxidant defenses
seldom affects lifespan in mice (Perez et al., 2009). This skeptical view is
consistent with the failure of a wide range of antioxidant drugs to
improve health or lifespan in humans (Dolara et al., 2012).
Increased resistance to oxidative injury thus seems often to accom-
pany increased longevity, but to be insufficient to increase lifespan on its
own. It is possible that elevated antioxidant mechanisms may be among
a suite of protective mechanisms controlled in parallel by anti-aging
drugs or mutations (Miller, 2009). A related idea proposes that some
cellular processes might regulate both lifespan and stress resistance
through independent mechanisms. For example, we have shown
previously that cells from longer-lived species show higher levels of
proteasome function and that this increase involves increased levels
of the immunoproteasome, perhaps as part of a general upregulation of
the MHC class 1 antigen presentation system (Pickering et al., 2015b).
Despite the paucity of evidence that increased antioxidant pathways can
improve lifespan in rodents, there is one report of increased longevity in
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mice in which catalase overexpression is targeted to mitochondria,
hinting that mitochondrial antioxidant defenses might be of particular
importance (Schriner et al., 2005). Marginal lifespan effects have also
been reported with overexpression of thioredoxin-1 in mice (Mitsui
et al., 2002; Perez et al., 2011).
Thioredoxin (TXN) is a small redox protein which both removes
oxidants and free radicals from the cellular environment and reduces
protein disulfide bonds once these are formed (Holmgren, 1989).
Thioredoxin reductase (TXNRD) reduces oxidized TXN thioredoxin while
simultaneously catalyzing conversion of NADPH into NADP+ (Holmgren,
1989). Thus, TXNRD controls the availability of reduced TXN. The TXN/
TXNRD pathway also represses apoptosis through inhibition of ASK-1
signaling (Saitoh et al., 1998). In mammals, there are three forms of
thioredoxin reductase: cytosolic TXNRD1, mitochondrial TXNRD2, and
TXNRD3, whose function is poorly defined and is thought to be
predominantly expressed in the testes (Conrad et al., 2006). In
Drosophila, there are two forms of thioredoxin reductase: cytosolic
Trxr-1, an orthologue of TXNRD1, and mitochondrial Trxr-2, an
orthologue of TXNRD2.
In this report, we show a correlation between TXNRD enzyme
activity and species lifespan using fibroblasts from birds, rodents, and
primates. In some clades, we found similar associations with glu-
tathione reductase activity, but did not see a correlation for any of the
other redox enzymes evaluated. The increase in TXNRD activity in the
longer-lived species is due to enhanced mitochondrial TXNRD2 with no
change in cytosolic TXNRD1 or TXNRD3. A similar increase in TXNRD2
is seen in tissues of several models of enhanced longevity in mice, and
in an analysis of mRNA levels from multiple tissues of primate species.
Lastly, we demonstrate that overexpression of mitochondrial TXNRD2,
but not cytosolic TXNRD1, can extend lifespan in Drosophila
melanogaster.
These data demonstrate that augmentation of mitochondrial thiore-
doxin reductase 2 is a conserved approach utilized by species from a
range of animal clades under selection for a long lifespan. Furthermore,
we demonstrate directly that augmentation of this enzyme is able to
extend organismal lifespan in Drosophila melanogaster. Our approach
shows the power of combining comparative biology cross-species
approaches with direct interventions in model organisms as a means
of discovering regulators of aging and lifespan. In addition, we identify
mitochondrial Thioredoxin reductase 2 as a new target, for basic and
applied research in aging.
Results
Thioredoxin reductase activity increases with species lifespan
in cultured fibroblasts
We were interested in whether cellular redox enzymes might be
differently active in cells from long- and short-lived species. To evaluate
this, a collection of primary fibroblasts was developed from 17 different
species of rodents, 15 species of primates, and 18 species of birds.
Lysates were collected from these samples and evaluated for function of
catalase, superoxide dismutase, glutathione reductase (GSR), thioredoxin
reductase, glutathione peroxidase, and peroxiredoxin activity. Higher
levels of total TXNRD activity were present in cells from long-lived
rodents, primates, and birds (Fig. 1A–C). A significant positive associa-
tion was also seen for GSR activity among primates and bird species,
with a similar trend (P = 0.08) for rodent species (Fig. 1D–F). We found
no significant association with lifespan for catalase, superoxide
dismutase, glutathione peroxidase, or peroxiredoxin activity (Fig. S1,
Supporting information).
Mitochondrial TXNRD2 and GSR are more abundant in
longer-lived species
Immunoblots were used to evaluate whether these associations between
species longevity and TXNRD andGSR activity reflect an increase in protein
levels of one or more forms of these enzymes. In such experiments, it is
important to ensure that antibody binding affinity was not altered by
interspecies sequence variation. For primates, it was possible to use
antibodies for TXNRD1 and TXNRD2 that targeted epitopes conserved
across all primate species for which sequence data are available. The
antibodies selected for evaluation of TXNRD3 and GSR in primates
recognize epitopes which varied in a small number of species, but these
variations were found not to affect antibody binding affinity, based on
ELISAs of the sequence variants (Fig. S2, Supporting information). For
rodents, it was not possible to identify antibodies that targeted epitopes
highly conserved across all of the rodent species, but we were able to use
antibodies that recognized specific epitopes in subsets of the rodent
species used and demonstrated that antibody binding affinity was not
altered (Fig. S2, Supporting information) within each species collection.
Immunoblot analysis was not performed on bird species, because the lack
of sequence data precluded selection of shared target epitopes.
For primates, the immunoblot data showed a positive association
between species lifespan and the mitochondrial isoenzyme, TXNRD2,
but no association with either of the two cytosolic forms, TXNRD1 or
TXNRD3 (Fig. 2A–D). Among rodents, too, only TXNRD2 showed a
significant association with species longevity (Fig. 2E–H). This increase in
TXNRD2 activity was associated with an increase in mitochondrial TXNRD
activity in longer-lived species with no increase in cytosolic TXNRD
activity (Fig. S3, Supporting information). A parallel analysis of GSR
protein levels found significant lifespan association in both rodents and
primates (Fig. S4, Supporting information).
Adjustments for phylogenetic relatedness, species body
mass, and mitochondrial content
When undertaking cross-species evaluations, it is important to consider
the effects of phylogenetic relatedness, which can lead to similar
outcomes (in this case TXNRD2 levels and longevity) in species that are
closely related and thus might have inherited genes that modulate both
traits through a shared ancestral history, even if the outcomes are not
related to one another through any causal pathway, direct or indirect. A
standardized phylogenetic-independent contrast analysis (Garland &
Adolph, 1994) showed significant association for lifespan vs. TXNRD
activity, and lifespan vs. TXNRD2 protein, in rodents and primates
(Fig. 3A–D). The phylogenetic-adjusted GSR regressionwas significant for
primates (P = 0.02) and showed a similar but nonsignificant (P = 0.12)
trend for rodents (Not shown). While the trends were statistically
significant, it is important to note that the primate immunoblot data
were heavily influenced by the diversion of the hominid apes (arrow on
Fig. 3B). These apes are substantially longer-lived and have much higher
levels of TXNRD2 and GSR than other primates. No such biases were
present in the other trends evaluated (Fig. 3).
Similarly, some experts have argued (Speakman, 2005) that associ-
ations between lifespan and biochemical traits can be misinterpreted if
each is a reflection of interspecies differences in body mass, which is
strongly associated with metabolic rates and thus with traits mechanis-
tically tied to metabolism. Adjustments for species mass can, however,
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lower statistical power and increase type II (false negative) rates, because
larger species of mammals and birds tend to be relatively long-lived.
Mass-adjusted regression analyses found significant relationships
between TXNRD activity, TXNRD2 protein, and GSR protein among
primates, and for TXNRD activity among rodents, with parallel but not
significant trends for TXNRD2 and GSR in the rodent species (Fig. 3E–H).
We also considered the possibility that the greater abundance of
TXNRD2 in long-lived species might reflect merely an increase in
mitochondrial content. To test this idea, we measured levels of porin
(voltage-dependent anion channel, VDAC) as an index of mitochondrial
mass and reran the regression analysis after adjustment for species
differences in porin concentration. We saw no association between
porin expression and species lifespan and found that the positive
association between TXNRD2 protein levels and species lifespan was
maintained after correction for mitochondrial content (Fig. S7, Support-
ing information).
TXNRD2 mRNA is elevated in multiple tissues in long-lived
primate species
Our data in rodent and primate fibroblasts show TXNRD2 to be elevated
in longer-lived species. We wished to evaluate whether this reflected
in vivo changes in one of more tissues in longer-lived species. To test this,
we performed a secondary analysis on a published RNA-Seq dataset of
multiple tissue types from 12 primate species (Peng et al., 2015). We
found a positive association between species lifespan and TXNRD2
mRNA for muscle, blood, colon, lymph node, pituitary, spleen, lung,
thymus, liver, brain, kidney, and bone marrow, that is, in all tissues for
which RNA data were available (Fig. 4A). Despite the limited statistical
power of a dataset with only 12 species, the trend reached statistical
significance for muscle, blood, colon, and lymph node. No such trends
were seen in the tabulated mRNA data for TXNRD1 or TXNRD2 (Fig. 4B),
or for GSR (Fig. S8, Supporting information).
Higher TXNRD activity and TXNRD2 protein levels in
slow-aging mice
Stimulated by these comparative interspecies results, we next evaluated
TXNRD in tissues of several varieties of laboratory mice in which aging
had been slowed, and lifespan increased, by single gene mutations. Snell
dwarf mice have a mutation in Pit-1, which blocks development of
portions of the anterior pituitary (Lewinski et al., 1984) and leads to
lower levels of growth hormone, thyroid hormones, and IGF-1. Snell
mice live about 40% longer than littermate controls, with both sexes
showing a strong effect (Flurkey et al., 2001). We found increased levels
(~29) of TXNRD2 in liver of male and female Snell dwarf mice (Fig. 5A,
B), and significant elevation in spleen (59), lung (29), kidney (1.59), and
thymus (2.59) (Fig. 5C), with no difference in stomach, muscle, brain, or
heart. We also found elevations of TXNRD2 in liver of Papp-A mice
(Fig. 5D), in which deletion of a protease specific for IGF-1 binding
proteins leads to extended longevity despite normal serum levels of GH
and IGF-1. Similarly, TXNRD2 was elevated in liver tissue from growth
hormone receptor knockout mice (Al-Regaiey et al., 2005), in which
global disruption of the growth hormone receptor leads to increased
longevity in both males and females (Fig. 5E).
As a control to separate factors which are linked to the longevity
phenotype in these mice from factors linked with the dwarfism
phenotype, we made use of a liver-specific growth hormone receptor
knockout. These mice have very low plasma IGF-1 and lack other
hepatic responses to GH, but have a normal lifespan (Dominick et al.,
2015). In contrast to the global GHR-/- mice, the liver-specific mutants
did not show any hepatic increase in TXNRD2 (Fig. 5F), suggesting that
the increase of TXNRD2 in the long-lived mutants may depend on
signals from other GH-sensitive tissues that modulate liver gene
expression.
We found that TXNRD enzyme activity parallels the results of these
tests of TXNRD2 protein. We saw a significant increase in total TXNRD
activity in Snell dwarf, Papp-A, and GHR-/- mice (Fig. 5G–K). Liver-
specific GHR-/- had no significant change in TXNRD activity (Fig. 5K).
The increases in TXNRD2 seen in Snell and GHR-/- mice remained
statistically significant after adjustment for mitochondrial mass using
porin (Fig. S7, Supporting information), but significance was lost in
Papp-AKO mice.
In addition to the mutations which extend mouse lifespan, we also
evaluated drugs that extend mouse lifespan. TXNRD2 was found to be
slightly, but significantly, elevated in mice which have been treated
with the drug nordihydroguaiaretic acid (NDGA), which extends mouse
lifespan in males but not females (Strong et al., 2008; Harrison et al.,
2014) (Fig. 5K). In these mice, a small increase in TXNRD activity was
also observed in male mice treated with NDGA but not in NDGA-
treated female mice (Fig. 5L). The increase in TXNRD2 reported in
NDGA-treated male mice lost statistical significance after correction for
mitochondrial load (Fig. S7, Supporting information). For this reason,
we cannot discount the possibility that the change seen in NDGA-
treated mice may reflect changes in mitochondrial abundance. In
Fig. 1 Thioredoxin reductase activity positively correlates with lifespan among
rodent, primate, and bird species. Glutathione reductase activity positively
correlates with lifespan among primate and bird species. (A–C) TXNRD activity in
primary fibroblasts from 17 species of rodents, 15 species of primates, and 18
species of birds. (D–F) GSR activity in primary fibroblasts from 17 species of
rodents, 15 species of primates, and 18 species of birds. Significance is assessed by
simple linear regression analysis. Error bars if present represent multiple individuals
assayed from the given species. Results for human fibroblasts are shown with an
‘H’ but are excluded from statistical analysis. MLS = maximum recorded species
lifespan in years.
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addition, we evaluated mice treated with rapamycin, acarbose, and
17-a-estradiol (Harrison et al., 2014), and mice exposed to a calorie
restriction diet, but found no significant change in TXNRD2 in the liver
of these mice (Fig. S9, Supporting information). Another group
has reported TXNRD2 (but not TXNRD1) to be elevated in skeletal
muscle and heart tissue in calorically restricted rats (Rohrbach et al.,
2006).
There is reasonable agreement between the effect size for the
TXNRD2 protein levels and the TXNRD enzyme activity. Differences
between these two assays are in any case not unexpected, in that the
TXNRD enzyme activity reflects a mixture of TXNRD1 and TXNRD2
enzyme action in an unknown proportion. The increases in TXNRD2 seen
in Snell and GHRKO mice remained statistically significant after
adjustment for mitochondrial mass using porin (Fig. S7, Supporting
information), but significance was lost in Papp-AKO mice.
Overexpression of mitochondrial Trxr-2 (orthologue of
TXNRD2) extends lifespan in Drosophila melanogaster
The data above showed association between expression of TXNRD2
and lifespan across species and in several varieties of slow-aging mice.
To directly test whether increases in TXNRD2 expression are sufficient
to increase lifespan, we constructed a strain of Drosophila that
contained an additional copy of Trxr-2 (Drosophila orthologue of
TXNRD2) fused to the upstream activating sequence (UAS) for use in
the bipartite GAL4-UAS expression system. Offspring from a cross to
the ubiquitous (RU486-dependent) driver-line GeneSwitch-Daughter-
less-GAL4 (GS-Da-GAL4) then allowed a test for lifespan effects under
adult-specific Trxr-2 overexpression compared to genetically identical
flies from the same cohort, in which Trxr-2 is expressed at
endogenous levels (Fig. 6A,B). Overexpression of Trxr-2 by feeding
the drug RU486 was found to extend lifespan in three independent
cohorts of mated female flies (Figs 6C and S9, Supporting informa-
tion). To rule out off-target effects of RU486 as the cause for lifespan
differences, we evaluated flies lacking either the UAS or the GAL4
transgenic construct. We found no change in Trxr-2 expression or
activity and no lifespan extension (Fig. S10, Supporting information).
RU486 treatment of GS-Da-GAL4 > UAS-Trxr-2 flies also increased
lifespan in two independent cohorts of male flies, although the effect
was smaller (Figs 6D–F and S9, Supporting information), consistent
with a smaller induction of Trxr-2 in males (as shown in Fig 6A). The
increase in lifespan in female flies was accompanied by diminished
age-associated reduction in muscle function and in rates of respiration
(Fig. 6G,H) suggesting a potential role for TXNRD2 in age-related
physiological decline. To evaluate whether the lifespan increase was
due to tissue specific effects, lifespan evaluations were also per-
formed using the driver lines GS-tub5-GAL4, GS-elav-GAL4 (neuronal-
specific), and GS-tigs-GAL4 (gut-specific), but no substantial lifespan
Fig. 2 Protein levels of mitochondrial TXNRD2 have a positive correlation with lifespan among primate and rodent species. No significant lifespan association for TXNRD1 or
TXNRD3. (A) Representative immunoblots for primate species. (B–D) Scatterplots of TXNRD1, TXNRD2, and TXNRD3 in primate species. (E) Representative immunoblots
for rodent species. The samples were split across two blots due to antibody affinity issues; see Fig. S2 (Supporting information). (F–H) Scatterplot for TXNRD1, TXNRD2, and
TXNRD3 for rodent species. Significance is assessed by simple linear regression analysis. Error bars if present represent multiple individuals assayed from the given
species. Results for human fibroblasts are shown with an ‘H’ but are excluded from statistical analysis. MLS = maximum recorded species lifespan in years.
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increase was observed under these drivers (Table S2, Supporting
information).
To determine whether lifespan extension is specific to the Trxr-2/
TXNRD2 isoform, we created UAS-fused transgenes containing each of
the three Drosophila Trxr-1 (TXNRD1 orthologue) isoforms (Trxr-1A,
Trxr-1B, and Trxr-1C). We found that in contrast to data for Trxr-2
overexpression, RU486-driven overexpression of any of these isoforms
failed to increase lifespan (Fig. 6I–K, Fig. S11, Supporting information).
These results imply that the lifespan effect is produced specifically
through overexpression of mitochondrial TXNRD2/Trxr-2 and not the
predominantly cytosolic TXNRD1/Trxr-1. Furthermore, the failure of
Trxr-1B (which is mitochondrial) to extend lifespan might point to
Fig. 3 Trends mostly remain significant after correction for phylogenetic relatedness and species body mass. (A–D) Adjustment for species phylogenetic relatedness for
(A) thioredoxin reductase activity in primates, (B) thioredoxin reductase 2 protein levels in primates, (C) thioredoxin reductase activity in rodents, and (D) thioredoxin
reductase 2 protein levels in rodents. (E-H) Adjustment for species body mass for (E) thioredoxin reductase activity in primates, (F) thioredoxin reductase 2 protein levels
in primates, (G) thioredoxin reductase activity in rodents, and (H) thioredoxin reductase 2 protein levels in rodents.
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functional differences between Trxr-1 and Trxr-2 as being more
pertinent to the lifespan effect than cellular distribution. Interpretation
of the lifespan results is somewhat complicated by background
differences, as the Trxr-1 transgenes were only available in a w1118
background, and the Trxr-2 transgene available only in a yw
background. It is possible that the effects of these transgenes might
differ in alternate background stocks.
Discussion
A collection of fibroblasts from multiple species in each of several
independent clades provides a powerful tool for evaluation of factors
involved in evolutionary adaptation in cell traits that affect aging rates
and lifespan. Early work in such systems relied on endpoints, such as
stress resistance or enzymatic activity, that could be evaluated without
the use of sequence-sensitive methods (Harper et al., 2007, 2011; Dostal
et al., 2015). The recent accumulation of genomic sequences from
multiple species has broadened the range and depth of such compar-
ative analysis, by allowing the use of immunoblotting for epitopes shared
among species (Pickering et al., 2015b), and development of RNA-seq
(Peng et al., 2015), and proteomic technologies (Wright et al., 2010) for
species known to have different lifespans.
In this investigation, a cross-species survey of rodent, bird, and
primate cell lines showed that levels of TXNRD correlated with species
lifespan, independently in multiple clades. Further investigation revealed
that the increase in activity appeared to reflect solely elevation of
TXNRD2, the mitochondrial form of TXNRD, in both rodents and primate
species. Analysis of a public RNA-Seq database showed that elevated
mRNA for TXNRD2 was characteristic of many internal tissues of longer-
lived primate species. Furthermore, we found higher levels of TXNRD2 in
multiple tissues of long-lived Snell dwarf mice, in two other varieties of
long-lived mutant mice, and in male mice treated with NDGA, a drug
Fig. 4 TXNRD2 mRNA (but not TXNRD1 or TXNRD3) is positively correlated with lifespan among primates in multiple tissue types. (A) Scatterplots of TXNRD2 mRNA
levels plotted against maximum lifespan among primate species. mRNA levels reflect secondary analysis of RNA-seq data from Peng et al. (2015). N varies from 6 to 12
species depending on tissue availability. (B) Summarized scatterplots of TXNRD1, TXNRD2, and TXNRD3. Red lines represent trends which are significant at P < 0.05,
red dashed lines P < 0.1, and black lines P > 0.1. N varies from 6 to 12 species. Significance is based on simple linear regression analysis.
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that extends lifespan only in males. The absence of TXNRD increase in
liver mice with a liver-specific GHR disruption suggested that control of
hepatic TXNRD may depend upon intertissue interactions that also
regulate mouse aging rate and lifespan, because liver-specific GHR
inactivation does not lead to a lifespan increase (Dominick et al., 2015).
Our finding of an association between TXNRD2/Trxr-2 levels/activity
and lifespan in several independent models was complemented by our
finding that overexpression of Trxr-2 in flies led to an increase in lifespan.
This work presents TXNRD2/Trxr-2 as an interesting new target for
regulation of aging rates and lifespan. However, the mechanism by
which TXNRD2/Trxr-2 might increase lifespan is still in need of further
investigation.
Our results are the first to suggest a role for thioredoxin reductase 2 as
a regulator of lifespan in primates, mice, or flies. There have, however,
been reports hinting at a role of thioredoxin reductase 1, or its substrate
thioredoxin 1, in lifespan regulation. For example, Orr et al. (Orr et al.,
2003) evaluated a series of transgenic flies bearing additional copies of
Trxr-1, together with catalase and/or superoxide dismutase. Lifespan in
five such stocks showed small and inconsistent results, with no stock
showing more than 9% increase over controls. Trxr-1 was not tested on
its own. In our study, we observed no lifespan extension under Trxr-1
overexpression in flies. Two studies of mice have reported that overex-
pression of TXN-1 (the substrate of TXNRD1) can extend mouse lifespan
(Mitsui et al., 2002; Perez et al., 2011). Mitsui et al. reported that when a
copy of human TXN-1 fused to a b-actin promoter is inserted into C57BL/
6 mice, median lifespan is increased 35% and maximum lifespan 22%,
but interpretation of this result is complicated by the very short median
lifespan, 20 months, of the control stock. Perez et al. crossed the same
allele onto the C57BL/6J stock, where the median control lifespan is 27–
30 months. They found that mice hemizygous for the TXN-1 transgene
did not show a statistically significant increase in mean or median lifespan
in either sex, and they saw no increase in the allele frequency in the
longest-lived 10%, although early mortality (10–25% of deaths) was
significantly reduced in two cohorts of males.
Prior evidence for an important role of mitochondrial antioxidant
defense as a regulator of aging/lifespan has been inconclusive (reviewed
in Jang & Van Remmen, 2009). Overexpression of mitochondrial SOD2
was reported to extend lifespan in flies (Sun & Tower, 1999) and yeast
(Longo et al., 1996). In contrast, knockdown or overexpression of
mitochondrial SOD2 seems to have little effect on lifespan in mice (Jang
et al., 2009). Overexpression of catalase specifically in mitochondria has
been reported to extend mouse lifespan, while catalase targeted to other
organelles did not appear to extend mouse lifespan (Schriner et al.,
2005). However, the authors do point out that backcrossing the
mitochondrial catalase line into a pure C57BL/6 background diminished
the lifespan extension. Our observation of a link between mitochondrial
TXNRD2 and lifespan in mammals and flies supports an argument for
mitochondrial antioxidant defense as an important determinant of
lifespan. However, this interpretation is complicated by our report that
when mitochondrial targeted TXNRD1 (Trxr-1B) is overexpressed in flies,
no lifespan increase is observed.
TXNRD2/Trxr-2 may affect aging and mortality through pathways
other than protection from oxidant injury. For example, TXNRD2 can
serve as a sensor of cellular stress and repressor of apoptosis. Its
substrate, TXN-2, represses signaling of apoptosis signal-regulating
kinase 1 (ASK-1) (Saitoh et al., 1998). Here, TXN-2 binds ASK-1 when
reduced but releases ASK-1 when oxidized. The release of ASK-1 causes
the activation of a pro-apoptotic response including p38 phosphoryla-
tion and JNK signaling (Tobiume et al., 2001). In addition, thioredoxin is
a competitive inhibitor of tumor necrosis factor-alpha (TNF-a) signaling
(Liu et al., 2000). TXNRD1/Trxr-1 and TXNRD2/Trxr-2 have distinct
regulatory functions (e.g., Zhang et al., 2004). As a consequence, the
apparent differences in the capacity to extend lifespan between
TXNRD1/Trxr-1 and TXNRD2/Trxr-2 might reflect these functional
differences instead of organelle localization.
Whether the association between lifespan and TXNRD2/Trxr-2 is a
product of improved mitochondrial oxidant defense or changes in
sensitivity to apoptotic signaling will form an interesting subject for
future investigation. In addition, further investigation into whether
our findings in flies can be recapitulated in mice will prove highly
informative.
Experimental procedures
Cell culture
Cells were cultured in DMEM (high-glucose variant; Gibco-Invitrogen,
Waltham, MA, USA) supplemented with 10% heat-inactivated fetal
Fig. 5 TXNRD2 protein and TXNRD activity are elevated in liver tissue from
multiple long-lived mouse models. (A) Representative immunoblots for Snell dwarf
liver tissue. (B) TXNRD2 protein levels in liver tissue from Snell dwarf mice, N = 6.
(C) TXNRD2 protein levels for multiple tissues types in male Snell dwarf mice,
N = 3. (D–F) TXNRD2 protein levels in liver tissue from Papp-A (N = 6), GHR-/-
(N = 6), and liver-specific GHR-/- (N = 4) mice. (G–J) TXNRD activity in liver tissue
from Snell dwarf, Papp-A, GHRKO, and liver-specific GHR-/- mice. (K–L) TXNRD2
protein levels and TXNRD activity in liver tissue from NDGA-treated mice, N = 6.
Significance was assessed by two-way ANOVA. T is shown in plots where the
mutation or drug has a significant effect. S is shown where sex has a significant
effect. t-Tests were performed only where there was a significant interaction
effect. A P-value table for these data is presented in Table S1 (Supporting
information).
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bovine serum and antibiotics (100 U mL1 penicillin, 100 lg mL1
streptomycin, and 0.25 lg mL1 of amphotericin B; Gibco-Invitro-
gen). Cells were incubated at 3% O2, hypoxic with respect to
atmospheric O2 concentration, to mimic their normal physiological
environment; the incubators were also maintained at 5% CO2, and
37 °C. Medium was replaced every 3–4days. For most experiments,
cells were seeded at 300 000 cells mL1 in either 6-well plates or
T75 flasks 48 h prior to assay. In most cases, media were replaced
with serum free media 24 h prior to assay as described previously
(Pickering et al., 2015a, 2015b). All cell lines used in experiments
were primary cell fibroblast lines either developed by the University
of Michigan or acquired from Coriell Cell Repository (Camden, NJ,
USA) as described in more detail previously (Pickering et al., 2015a,
2015b).
Thioredoxin reductase activity assay
Thioredoxin reductase activity was measured through changes in the
spectral properties of thioredoxin. Thioredoxin has threefold greater
fluorescence at ex280 nm em340 nm when in a reduced state in contrast
to an oxidized state (Stryer et al., 1967). Samples were lysed in 50 mM
potassium phosphate and 1 mM EDTA, pH 7.5, by freeze fractionation
(coupled with sonication at 20% for 10 s on ice for Drosophila samples).
1 lg of cell lysate (based on BCA assay) was incubated with 1 lM of
oxidized thioredoxin-1 or thioredoxin-2 (T8690, SRP6073; Sigma-
Aldrich, St. Louis, MO, USA). Fluorescence was assessed under ex280 nm
em340 nm. Background fluorescence (lysate in the absence of substrate)
was subtracted from readings. Measurements unless stated otherwise
were of total cellular TXNRD activity.
Fig. 6 Overexpression of Trxr-2
(orthologue of TXNRD2) increases lifespan
in flies. (A) Trxr-2 mRNA levels in GS-Da-
GAL4 > UAS-Trxr-2 mated female flies in
the absence and presence of RU486
inducer, N = 12 per condition. (B) Trxr
activity in GS-Da-GAL4 > UAS-Trxr-2
mated female flies, N = 12 per condition.
(C) Lifespan of GS-Da-GAL4 > UAS-Trxr-2
mated female flies, N  200. (D) Trxr-2
mRNA levels in GS-Da-GAL4 > UAS-Trxr-2
mated male flies in the absence and
presence of RU486 inducer, N = 12 per
condition. (E) Trxr activity in GS-Da-
GAL4 > UAS-Trxr-2 mated male flies,
N = 12 per condition. (F) Lifespan of GS-
Da-GAL4 > UAS-Trxr-2 mated male flies,
N  250. (G) Number of times individually
housed flies crossed a 3-cm mark per hour
measured by a TriKinetics activity monitor,
N = 16, young = 10 days, old = 30 days.
Climbing capacity was not evaluated at the
older time point (60 days) because few flies
are able to climb to 3 cm at this age.
(H) O2 consumed per h, as in Yatsenko
et al. (2014), N = 16, young = 10 days,
old = 60 days. No significant decline in O2
consumption was observed at the earlier
(30 days) time point. In bar charts, values
are shown as mean  SEM and
significance is based on t-test analysis
where *P < 0.05, **P < 0.01, and
***P < 0.001, ****P < 0.0001. (I) Lifespan
of GS-Da-GAL4 > UAS-Trxr-1A mated
female flies, N  200. (J) Lifespan of GS-
Da-GAL4 > UAS-Trxr-1B mated female
flies, N  200. (K) Lifespan of GS-Da-
GAL4 > UAS-Trxr-1C mated female flies,
N  200. Significance for survival data is
based on the log-rank test. UAS-Trxr-2 flies
are in a yw genetic background with a
typical extinction age of 80 days. UAS-Trxr-
1A-C flies are in a w1118 genetic
background with a typical extinction age of
100 days.
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Fly stocks
To generate UAS-Trxr-1A, UAS-Trxr-1B, UAS-Trxr-1C, and UAS-Trxr-2
transgenic flies, cDNAconstructs for the respective geneswere cloned into a
pUAST-attb vector and submitted for sequencing analysis. The correctly
constructed vectors were then sent to BestGene, Inc. (Chino Hills, CA, USA)
for injection into attp-containing Drosophila embryos. Flies were screened
for gene overexpression through qPCR under a cross with GS-Da-GAL4. Fly
stocks with robust overexpression profiles were then backcrossed into our
yw genetic background for a minimum of eight generations.
Fly survivorship assays
Fly stocks were maintained on a standard cornmeal-based larval growth
medium and maintained in a temperature- and humidity-controlled
environment (25 °C, 60% humidity) with a 12:12-h light:dark cycle.
Age-matched emerged flies were collected within a 48-h period and
allowed to mate on standard media. After 48 h, the flies were lightly
gassed using CO2 and sorted by gender (25 per vial) onto the
experimental food. The experimental food consisted of either 10%
sugar/yeast containing 200 lM RU-486 (RU486+) or ethanol vehicle
(RU486). A minimum of eight independent vials were set up per
gender/experimental treatment. The flies were housed in the 25 °C
humidified incubator with 12:12-h light:dark cycles for their entire
lifespan. Flies were given fresh food every 2–3 days and the number of
dead recorded using dLife software. This software was also used to blind
and randomize the vials with respect to tray distribution.
Study approval
All mouse studies performed were approved by the University Commit-
tee on Use and Care of Animals at the University of Michigan (Ann
Arbor, Michigan, USA) on December 7, 2012.
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